US Cannabis: Stifel Expects “Limited To No Sales Growth”

Earlier this month, Stifel-GMP came out with their US cannabis second quarter preview, calling the bottom on the drawdown but resetting their estimates for many cannabis names in their coverage to include “limited to no sales growth across most markets.” The analysts say that an elevated recession risk, challenging macro environment, and price compression/margin erosion are being added to the list of headwinds potentially affecting the sector as the reason for the resetting of expectations.

Though Stifel believes that some of these potential headwinds will be offset by a better geography mix and thinks that the moat is widening for those who, “enjoy greater access to capital, robust cash generation potential, and the ability to capitalize on distressed assets to fill white space.” They reiterate their bullishness on the sector as a whole.

Heading into the second quarter results, Stifel says that Curaleaf Holdings (CSE: CURA) is their favourite and tells investors to be cautious on TerrAscend Corp (CSE: TER) while saying that Trulieve Cannabis (CSE: TRUL), Cresco Labs (CSE: CL), and Green Thumb Industries (CSE: GTII) are all the second half of 2022 stories. They believe that Curaleaf is the company with the highest chance of exceeding expectations for the second quarter. While they comment that Terasecnd is basically too hard to forecast, putting it in the penalty box this quarter as a result.

Below you can see Stifel’s updated price targets and ratings; most notably, Trulieve and Green Thumb’s price targets got absolutely pummelled, dropping from $125 and $60 to $40 and $30, respectively.

The cuts come after Stifel started to right-size their assumptions while also “considering the rising rate environment and the valuation re-rating of the broader market,” and used the alcohol industry as their guide for multiples.

On the price headwinds potentially facing these companies, Stifel believes it will be the East Coast states that will be hit the hardest when price compression happens due to the delta between legal and illicit pricing. As a result, they are factoring in price compression for all of 2023 and 2024. Though they add that some companies will be able to offset this headwind due to volume growth and continued CAPEX investments in other limited license states. They write, “margin expansion mainly stems from better geography mix with NJ and IL leading the way and rising vertical integration making accretive contributions.”

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

Stifel believes that the market is currently pricing in 280E and won’t be going away for some time, though they believe that long-term investors should assume that 280E is “eventually addressed.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

TerrAscend Secures US$120 Million Term Loan To Fund Ilera Earn-Out Payment

TerrAscend Corp (CSE: TER) this morning announced that it has closed on a US$120 million...

Friday, December 18, 2020, 09:53:41 AM

Hexo: Canaccord Raises Price Target To $1.25 Following Q1 Results

Yesterday, Hexo Corp (TSX: HEXO) (NYSE: HEXO) released its fiscal first quarter 2021 financial results....

Tuesday, December 15, 2020, 11:05:36 AM

Tilray: Haywood Reiterates Hold Rating, $16.50 Price Target

With the Aphria, Tilray (NASDAQ: TLRY) merger finalized and Aphria shares consolidated earlier this month,...

Wednesday, May 19, 2021, 03:38:00 PM

Canaccord’s Digital Asset Symposium Sees Michael Saylor Push Bitcoin As A Hedge Against Uncertainty

On February 15th, Canaccord Genuity hosted their fourth consecutive Digital Assets Symposium, which included a...

Sunday, February 27, 2022, 11:14:00 AM

Canaccord Lowers Aurora Cannabis Price Target To $5 Following Q2 Earnings

On February 10th, Aurora Cannabis (TSX: ACB) reported its fiscal second quarter 2022 results. The...

Sunday, February 13, 2022, 05:16:00 PM